Physician

John Lee Anthony, M.D.

According to 2025 Medicare claims, John Anthony, M.D. (NPI: 1184790479) practices dermatology in the Montgomery, AL market, with the plurality of this provider's patient population coming from Montgomery, AL. This provider's primary affiliated billing organization is MONTGOMERY DERMATOLOGY, P.C. (NPI: 1982877619; TIN: 26-2188771) and primary practice location at 36106-3080.

Anthony's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 559 traditional Medicare patients, billed 3,758 HCPCS/CPT codes, and received $168,658 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 984 prescription claims across 361 beneficiaries totaling $639,941 in drug costs, led by Rinvoq (Upadacitinib). Open Payments data shows 162 records totaling $3,303. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $396,445 to $168,658. In contrast, Part D prescription costs have risen steadily, from $361,780 to $639,941. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$198K$396K2015 Medicare payment: $396,445 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $375,204 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $279,758 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $256,979 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $272,417 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $200,007 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $209,449 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $217,881 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $187,933 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $168,658 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,37010,180$396,445
20161,40710,289$375,204
20179986,978$279,758
20189656,390$256,979
20198805,800$272,417
20207534,753$200,007
20217344,633$209,449
20227484,711$217,881
20236504,055$187,933
20245593,758$168,658

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$320K$640K2015 Drug cost: $361,780 (USD; Tot_Drug_Cst)2016 Drug cost: $421,299 (USD; Tot_Drug_Cst)2017 Drug cost: $390,157 (USD; Tot_Drug_Cst)2018 Drug cost: $437,839 (USD; Tot_Drug_Cst)2019 Drug cost: $370,763 (USD; Tot_Drug_Cst)2020 Drug cost: $312,734 (USD; Tot_Drug_Cst)2021 Drug cost: $570,065 (USD; Tot_Drug_Cst)2022 Drug cost: $524,451 (USD; Tot_Drug_Cst)2023 Drug cost: $561,213 (USD; Tot_Drug_Cst)2024 Drug cost: $639,941 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153491,019$361,780
20163661,052$421,299
20174031,132$390,157
2018349942$437,839
2019348977$370,763
20203331,050$312,734
20213761,034$570,065
2022344996$524,451
2023337888$561,213
2024361984$639,941

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths284356$70
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more415607$56
11102Biopsy of related skin growth, first growth181218$51
17000Destruction of precancer skin growth, 1 growth329483$29
17003Destruction of precancer skin growth, 2-14 growths2331,348$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RinvoqUpadacitinib13390$79,224
OtezlaApremilast16480$76,550
Cosentyx Sensoready (2 Pens)Secukinumab11308$75,827
AcitretinAcitretin11468$6,739
Clobetasol PropionateClobetasol Propionate671,495$3,617

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.162$3,303ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John Lee Anthony, M.D.?

Tedicare shows public-source Medicare data for John Lee Anthony, M.D. (NPI 1184790479), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Lee Anthony, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Lee Anthony, M.D.?

John Lee Anthony, M.D. is linked to MONTGOMERY DERMATOLOGY, P.C. (billing NPI 1982877619) in the available physician profile data.

Does John Lee Anthony, M.D. have Open Payments data?

John Lee Anthony, M.D. has 162 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.